As more agents approach the clinic, it is imperative for researchers to consider the design and conduct of immuno-oncology clinical trials. Given the diversity of agents in this newly tapped field, researchers may encounter unique challenges for site selection, patient selection, biomarker selection and imaging for assessing patient responses.
Read More
Dr. El Mustapha Bahassi, Associate Director of Clinical Laboratories at Medpace, highlights the biomarker landscape in immuno-oncology clinical research.
Read More
Medpace Imaging Core Lab has experience and expertise in autoimmune imaging using conventional and molecular imaging methods.
Read More
In a recent PharmaVoice article “Brain Wave: Breakthroughs Bring New Hope to CNS”, Dr. Rick Scheyer, Vice-President, Medical Affairs at Medpace, provides comment on the state of neurodegenerative diseases and related clinical trials.
Read More
This year at AAPS PharmSci 360, scientists from Medpace’s bioanalytical laboratory will be presenting two scientific posters regarding new methods for biomarker assay validation. Stop by Booth #605 at the conference for more information.
Read More
As a full service, global CRO with an integrated central lab, Medpace has the scientific, operational and regulatory expertise to manage your celiac disease clinical trial.
Read More